ESTRO 2024 - Abstract Book

S5698

RTT - Patient experience and quality of life

ESTRO 2024

Count %

Brain

2

5,00%

Breast

9

22,50%

Gynaecological 2

5,00%

Haematological 3

7,50%

Tumour

Site

Groups

Head and neck 1

2,50%

Metastasis

2

5,00%

Prostate

19

47,50%

Rectal

2

5,00%

70-74

13

32,50%

75-84

23

57,50%

Age

85+

4

10,00%

Female

15

37,50%

Sex

Male

25

62,50%

Ambulatory and capable of all selfcare 4

10,00%

Fully active

12

30,00%

ECOG PS

Restricted

in

physically strenuous activity

24

60,00%

Yes

3

7,50%

Caregiver

No

37

92,50%

Curative

38

95,00%

RT intent

Palliative

2

5,00%

No

19

47,50%

Polymedicated (≥5 drugs)

Yes

21

52,50%